Results in 1-6 Months*
Free, Fast & Discrete Delivery
GMC Registered Doctors
From £149.00 £109 / month
Take Control of Your Weight – Backed by Real Results and Medical Expertise
Take Control of Your Weight – Backed by Real Results and Medical Expertise
Clinically Proven Treatment
Supervised by GMC Registered Doctors
Discreet, Convenient Service
Effectiveness
Average 15-21% Weight Loss*
Format
Easy Injection
Results
In 1-6 Months*
Online Approval time
Less Than 5 Minutes
.avif){kind=logo}
Achieve your goals with transparent, affordable pricing for our medically supervised weight loss injections.
From £199.00 £149 / month
From £149.00 £109 / month
Here's what to expect from our science-based service.
Complete a quick, secure medical questionnaire — it only takes a few minutes. Your answers will help our licensed providers understand your health profile and weight loss goals.
A board-certified provider reviews your submission. If approved, they’ll prescribe Mounjaro and create a custom plan tailored to you. We’re here to answer any questions along the way.
Your prescription is shipped discreetly to your door through a licensed UK pharmacy. Start your journey with ongoing support and guidance from our care team.
Effective solutions for weight loss backed by our clinical team.
Clinically-proven weight loss
From £199.99 £149.99 / month
Clinically-proven weight loss
From £149.00 £109.00 / month
Start your online consultation today. If you're eligible, you'll quickly receive your clinically prescribed medication.
Lose weight and transform the way you think about food. Boost your fitness, energy levels, and confidence along the way.
With ongoing support, build sustainable lifestyle habits that help you maintain your weight loss long term.
Mounjaro (tirzepatide): Based on tirzepatide once weekly for 72 weeks in the SURMOUNT-1 trial. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A & the SURMOUNT-1 Investigators. Tirzepatide once weekly for the treatment of obesity. The New England Journal of Medicine. 2022.*
Wegovy (semaglutide): Based on semaglutide once weekly for 68 weeks in the STEP 1 trial. Wilding JPH, Rubino D, Davies MJ, et al. Once-weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine. 2021. Results measured in participants who adhered to the dosing schedule and reached the maximum dose of semaglutide.*
Copyright © WeightlossRx 2025
